Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia

Journal of Infection and Chemotherapy

Volumn 9, Issue 1, 2003, Pages 40-45

  Kaptan, Kürşat ^a   Uǧur Ural, Ali ^a   Çetin, Türker ^a   Avcu, Ferit ^a   Beyan, Cengiz ^a   Yalçin, Atilla ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acute leukemia; Antifungal prophylaxis; Fungal infections; Itraconazole

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CEFEPIME; CYTOTOXIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; VANCOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; HEART ARRHYTHMIA; HUMAN; LEUKEMIA; LEUKOCYTE COUNT; MALE; MORTALITY; MYCOSIS; NEUTROPENIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH DISEASE; STOMACH IRRITATION;

EID: 0037367618     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-002-0207-5     Document Type: Article

References (22)

1. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(Suppl 1):S43-S53.
2. Bodey GP. Infection in cancer patients: a continuing association. Am J Med 1986;81:11-26.
3. Todeschini G, Murari C, Bonesi LR, Pizzolo G, Amaddi G, Ambrosetti A, et al. Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1993;12: 614-8.
4. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51.
5. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis 1995;171:1545-52.
6. Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Ann Intern Med 1993;118:495-503.
7. Anaissie EJ, Kontoyiannis DP, Huls C, Vartivarian SE, Karl C, Prince RA, et al. Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J Infect Dis 1995;172:599-602.
8. Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, D'Antonio D, et al. and the GIMENIA Infection Program. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann Intern Med 1994;120:913-8.
9. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New Engl J Med 1991;325:1274-7.
10. Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive aspergillosis. Am J Med 1994:97:135-44.
11. Van Cutsem J. In vitro antifungal spectrum of itraconazole and teatment of systemic mycoses with old and new antimycotic agents. Chemotherapy 1992;38(Suppl 1):3-11.
12. Vreugdenhil G, Van Dijke BJ, Donnelly JP, Novakova IR, Raemaekers JM, Hoogkamp Kostanje MA, et al. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leuk Lymphoma 1993;11:53-8.
13. Bohme A, Just-Nubling G, Bergmann L, Shah PM, Stille W, Hoelzer D. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with hematological malignancies. J Antimicrob Chemother 1996;38:953-61.
14. Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. Clin Infect Dis 1999;28:250-5.
15. Prentice AG, Bradford GR. Prophylaxis of fungal infections with itraconazole during remission-induction therapy. Mycoses 1989;32(Suppl 1):96-102.
16. Thunnissen PL, Sizoo W, Hendriks WD. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients. Neth J Med 1991;39:84-91.
17. Tricot G, Joosten E, Boogaerts M, Vande Pitte J, Cauwenbergh G. Ketaconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results from two nonrandomized studies. Rev Infect Dis 1987;9(Suppl 1): S94-9.
18. Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW. A randomised controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. Br J Haematol 1999; 105:901-11.
19. Wilcox CM, Darouiche RO, Laine L, Moskovitz BL, Mallegol I, Wu J. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. J Infect Dis 1997:176:227-32.
20. Schaffner A, Schaffner M. Effect of prophylactic fluconazole the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. J Infect Dis 1995;172:1035-41.
21. Gotzsche PC, Johansen HK. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. BMJ 1997;314: 1238-44.
22. Phillips P, De Beule K, Frechette G, Tchamouroff S, Vandercam B, Weitner L, et al. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS. Clin Infect Dis 1998;26: 1368-73.